Why haven't I lost weight this week on Mounjaro?

Step 1: Understand what the scales are actually measuring

When you step on the scales after a week on Mounjaro and see no change, the number is capturing total body weight, not body fat alone. Water makes up roughly 60% of body weight, and it moves constantly. A saltier meal, a hard workout, a hormonal shift mid-cycle, or even a night of disrupted sleep can add 1–2 kg of water weight overnight. That same weight disappears within a day or two without any change to fat stores at all.

This is why prescribers look at trends across four to six weeks, not individual weigh-ins. The NHS patient information for tirzepatide is clear that the medicine works alongside a reduced-calorie diet and increased physical activity over time, it is not a weekly event. If you are weighing yourself every morning, you are almost certainly seeing fluid noise rather than a true picture of progress.

One practical shift: pick one consistent moment to weigh yourself each week, the same day, same time, before eating. Many people find first thing on a Tuesday, before breakfast, gives the most stable reading. That's it. One data point per week, compared across the month, tells a far more accurate story than daily fluctuations.

Step 2: Recognise the difference between a plateau and a bad week

A single week without movement is not a plateau. A plateau, in the clinical sense, is four or more consecutive weeks of no meaningful change despite being consistent with your dose, diet and activity. Plateaus are well-documented in weight management and have a straightforward biological explanation: as body weight falls, the body reduces its resting energy expenditure to compensate. It takes fewer calories to maintain a lighter body, so the same deficit that produced results in month one may produce less by month three.

Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) to reduce appetite and slow gastric emptying. In SURMOUNT-1, the largest phase-3 trial, participants lost around 20–21% of body weight over 72 weeks at the highest dose, published in the New England Journal of Medicine. That average contains a wide range of individual trajectories, many of which included flat periods. A pause in the trend is not the end of the trend.

If you are approaching a genuine plateau (several weeks of no change) the right response is a conversation with your prescriber, not stopping treatment unilaterally. Dose titration, reviewing what you are eating, and assessing protein intake are all clinical tools available at that point. Our Mounjaro treatment information explains how the prescribing process is structured around exactly these kinds of ongoing reviews.

Step 3: Check the factors that blunt Mounjaro's effect

Even with tirzepatide reducing appetite, several factors can prevent that advantage from translating into visible weight loss on the scales. The most common ones our prescribers hear about are worth naming directly.

Eating back what the medicine saves. Tirzepatide reduces hunger, it does not enforce a calorie deficit automatically. If portion sizes have crept back up, or high-calorie drinks or snacks have slipped in, the appetite reduction can be partially offset without the person noticing.

Protein and fibre gaps. As overall intake falls, protein is often the first macronutrient to drop. Low protein accelerates muscle loss alongside fat, slows metabolism and reduces satiety, all of which slow visible progress. Prioritising protein at each meal (around 25–30g per sitting) matters more on these medicines, not less.

Sleep and stress. Poor sleep raises cortisol, which drives fluid retention and appetite for high-calorie foods. Chronic stress has the same effect. Neither cancels the medicine, but both can mask its impact on the scales for days at a time.

Activity levels. Strength training preserves muscle during rapid fat loss. Muscle tissue is denser than fat, some people lose fat and gain muscle simultaneously, and the scales stay flat while body composition improves measurably. If your clothes are fitting differently, that is relevant data the scales do not capture.

For a fuller look at why you may not have lost weight on Mounjaro, including what to do if progress has stalled rather than just paused, the clinical distinctions are covered in more depth there.

Step 4: Know when to raise it with your prescriber

Some situations go beyond the normal week-to-week variation and are worth flagging. If you have not lost any weight on Mounjaro across four or more consecutive weeks, that is a clinical question worth raising with your prescriber rather than one to solve alone by adjusting what you eat or how much you exercise. If your appetite has returned significantly between doses, or if you are experiencing side effects that are disrupting eating or sleep, those are also situations to flag.

The NICE appraisal of tirzepatide (TA1026) notes that continuing treatment should be reviewed if there is less than 5% weight loss after six months at the highest tolerated dose. That is the formal review point, but a conversation with your prescriber can happen well before that if something feels off.

At nume, every repeat order goes through a fresh clinical review. A real prescriber reads your update, not a form that gets auto-processed. If you are unsure why you have not lost any weight on Mounjaro, that review is the right place to raise it, and you can also contact the team directly via our support page if something is pressing between orders.

If you are wondering whether tirzepatide is right for you in the first place, or thinking about starting, our prescribers are available seven days a week. Check your eligibility through a free consultation, the clinical assessment is where these individual questions get proper answers.

For broader context on how tirzepatide fits into private weight management, the Mounjaro pricing page sets out what a legitimate private prescription includes, and if the scales have stayed stubbornly still from the very beginning, our guidance for people who have lost no weight on Mounjaro at all covers that specific situation in more detail.